Dow Work in process increased by 18.3% to $1.47B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.2%, from $1.37B to $1.47B. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 4.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.41B | $1.56B | $1.62B | $1.86B | $1.99B | $1.63B | $1.48B | $1.46B | $1.26B | $1.26B | $1.23B | $1.32B | $1.36B | $1.41B | $1.32B | $1.37B | $1.37B | $1.30B | $1.24B | $1.47B |
| QoQ Change | — | +10.4% | +3.5% | +15.0% | +7.4% | -18.5% | -9.2% | -1.2% | -13.4% | -0.6% | -1.7% | +6.8% | +3.0% | +4.0% | -6.2% | +3.4% | -0.2% | -4.8% | -4.7% | +18.3% |
| YoY Change | — | — | — | — | +41.0% | +4.2% | -8.6% | -21.5% | -36.7% | -22.8% | -16.4% | -9.6% | +7.5% | +12.4% | +7.2% | +3.8% | +0.6% | -7.9% | -6.3% | +7.2% |
| % of Inventories | 19.6% | 20.7% | 20.6% | 22.1% | 22.0% | 19.7% | 19.8% | 20.2% | 18.7% | 19.3% | 19.3% | 19.4% | 19.9% | 19.9% | 19.0% | 18.9% | 19.2% | 18.5% | 17.7% | 20.3% |
| Share Change | — | +1.1pp | -0.2pp | +1.6pp | -0.1pp | -2.3pp | +0.1pp | +0.5pp | -1.5pp | +0.6pp | +0.1pp | +0.0pp | +0.5pp | -0.0pp | -0.8pp | -0.1pp | +0.3pp | -0.7pp | -0.8pp | +2.5pp |